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INTRODUCTION t
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TUBERCULOSIS Is a ohrmlc wasting disease which from 
archaeological'*' evidence has afflicted mankind since early 
antiquitya An excellent description of the disease, referred 
to as phthisis* is due to Hippocrates* and some of the 
earlier remedies such as Inorganic arsenlcals* pine~oil* 
calcium salts* tannins* chaulmoogra oil* mercury and gold 
salts date from his perlodo The wide-spread Incidence of 
tuberculosis and the ineffectiveness of the earlier remedies 
has resulted in an intensive search for substances which 
would be effective in the clinical control* and eradication 
of the diseaseo
The causative organism Mycobacterium tuberculosis was 
first isolated by Koch In 18820 Various forms of tuberculosis
such as miliary tuberculosis (galloping consumption)* 
tubercular meningitis* pulmonary tuberculosis* tuberculosis 
empyema ( characterised by the accumulation of pus in the 
chest cavity)* lupus (tuberculosis of the skin) and scrofula 
(tuberculosis of the lymphatic glands) are knowno The 
disease begins by ingestion of the invading tubercle 
bacillus by normal mono«nuclear phagocyteso The cells
increase in slxe* the nuclei enlarge and become epithelold* 
Fusion of several eplthelold cells then takes place to give a 
”Langhan or Giant cell”* and this Is followed by the formation 
of nodules visible to the naked eye0 With the progressive 
growth of the nodule adjacent tissue cells are pushed aside 
and start dying from nutritional deficiencies caused by the
2o
pressure of the expanding tubercle *> If multiplication of the 
bacillus is not checked* the central portion of the tubercles 
die and become necrotic0 The necrotic cells lose structure and 
outline and the nuclei form a %aseous mass'* 0 This process is 
known as caseation and occurs In practically all cases of the 
disease6 The softening of the gaseous area allows imprisoned 
tubercle bacilli to become free and thus infect new siteso 
Healing often takes place by toxic irritation stimulating the 
fibroblaststo increased activity and deposition of calcium 
phosphateo This process is known as fibrosis and calcificatlono
Such healing will occur only If the resistance of the patient is
reasonably high and/or Invasion Is not too severe0 If the
resistance is low and Invasion great* rapid spread of bacilli
may occur9usually through the bronchi or blood stream and
this may prove fatalo Pulmonary tuberculosis Is the most 
common form of tuberculosis because Infection takes place by 
direct invasion of the lungs with Infected material0 Primary 
Infection may be followed by secondary Infection after a short 
periody This often results in a more acute local reaction* 
probably because the previous invasion leaves the patient 
hypersensitive to tuberculin proteln0
The great decline in mortality due to tuberculosis may 
be attributed to a number of factors 0 The major contribution 
is due to wide-spread X«ray campaigns which facilitate early 
diagnosis* and to the discovery of several antituberculosis 
agents i In spite of this great improvement sustained effort 
is necessary if a corresponding change in morbidity Is to be 
achieved An ideal chemotherapeutic agent should fulfil the
following requirements:
(X) It should be non« toxic to the patient and should 
rapidly relieve all symtoms of acute disease* 
and prevent relapse0
(2) It should be easily administered* preferably 
orallyo
(3) It should be cheap to manufacture* and easily 
stored without decomposItiono
ACID HYDRAZIDBS IN THE CHEMOTHERAPY OF TUBERCULOSIS
The activity of the vitamin nicotinamide was first
p
discovered in France by Chorine in 1945* who showed that 
it had a marked delaying effect on the development of the 
diseaseo He further showed that antitubercular and vitamin 
activity were unconnected; this assumption was borne out by 
the fact that nicotinic acid* despite its vitamin activity* 
was not tuberculostatico This important discovery passed 
unnoticed until McKenzie® and his eo«workers in 1948 made a 
similar observation during the screening of a large number 
of substances for tuberculostatic activity*, In order to 
settle whether the tuberculostatic effect of nicotinamide and 
its derivatives was a function of vitamin activity* they 
prepared a number of derivatives and found that they either 
exhibited no tuberculostatic activity or decreased activity 
with a corresponding Increase In toxicity0 They thus
concluded* contrary to Chorine* that the tuberculostatic and 
vitamin activity were relatedo As a consequence of this* 
other vitamins were also examined but all were found to have
no inhibitory action on th© tubercle bacillus* with th© 
exception of Riboflavin which showed only slight activity**© 
This postulate was subsequently proved wrong when 
3»&minoisoniootinic acid (1) and its methyl ester were 
found to possess antituberculosis activity* although they had 
no vitamin activityo These compounds not only have a 
carboxyl group in a different position but also have another 
substituent in the ring® This suggested that tuberculostatic 
^activity might exist in a wide variety of pyridine derivatives0
This possibility was investigated by Fox^ who synthesised a 
number of pyridine oarboxyllc acids for testlngo Whilst all 
these compounds proved to be of little value in the 
treatment of the disease* it revealed that any positional 
or structural deviation from 3-aminoisonicotinio acid* such 
as reduction or acylatlon* completely supressed tuberculostatic 
activityo Further investigation along this line was therefore 
abandoned^
With the discovery of p <=> acetamidobenzaldehyde 
thiosemioarbazone (II) (Tlblone) as an active synthetic 
tuberdulostat* another field of investigation opened up<>
This investigation started originally with Domagk*s5»6 
observation that of the many sulphonamldes known only two0 
viz sulpha thiazol$ (III) and the sulphathiadlazole (IV) 
showed limited in vivo tuberculostatic actlvityo
5o
(II) (III)
CH
(IV)
The parallel chemical behaviour of nitrobenzene and 
pyridine derivatives led ta the synthesis and study of 
laonl cot Inaldehyde thlosemioarbazone by Fox7*4q 1 ^ 0  early 
attempts to obtain the desired thloseoicarbazone met with 
failure because of the unstable nature of isonicotlnaldehyde 0 
However by a modified HdTadyen and Steven’s® reaction Fox^ 
was able to prepare the compound by the following series of 
reactions &
0»HH»NH«30oC&8j
(VI)(V)
(VII)
6o
Two positional isomers plcollnaldehy&e thiosemicarbazone 
(VIII > and nleotlnaldehyde thlosemioarbazone (IX) were 
prepared In a similar mannero
(VIII)
Of the three Isomeric thlosemloarbasones, only 
isonlootlnaldehyde thlosemioarbazone and nicetInaldehyde 
thlosemioarbazone proved to be active antituberculosis 
agentsa the former being more active than TlblonCo
In the view of the activity of the jB and V  - isomers * \ 
it seemed desirable to prepare some closely related 
compounds in the hope of discovering additional structures 
with antituberculosis activity 0 Accordingly, the 
arylldene group was replaced by an acyl group and 
thlosemioarbazldes of isonlcotinlo acid (X), nicotinic 
add, benzoic acid and p«nltrobenzoio acid were prepared 0 
These compounds showed no significant anfcltabormaloata 
actlvityo
7o
In order to determine the effect of so filial group 
on the ^feltuberndlo&lsactivity, methyl*-4^gyridyi ketone 
thlosemioarbazone (XI JZb ), ethyl 4~pyrldyl ketone 
thlosemioarbazone (XI} jRaSt) and propyl* d^pyrldyl ketone 
thlosemioarbazone (XIjRsPr) were prepared by the method of 
Kol^off and 2kinter^0
S
(XI)
Of these three compounds only compound (XI^R^tjs} proved to 
be activeo It could not, however, be used to treat 
Intranasal infection in mice as the therapeutic dose 
exceeded the maximum tolerated dose0 The Isosterie 
semioarbazones were also actlve0 It appeared therefore that 
the pyridine nucleus offered a promising starting point 
for synthetic tuberculostats and that the p andV« positions 
were the ones of choice for antituberculosis activity 
among the pyridine aldehyde thioaemlcarbazo'^es o
During attempts to establish a structure - activity 
relationship, two intermediates, isonleotlnlo acid 
hydrazlde (Isonlazld) (V) and Its benzeneaulphonyl 
derivative (VI), were obtained In the preparation of 
isonleotlnaldehyde thlosemioarbazone0 These two compounds, 
because of thsirrelation to the structure under Investigation, 
were also tested for antltubercular aotlvlty0 The
benzenesulphonyl derivative showed no activity, but 
laonleotlnlo add hydrazlde was found to be even more 
active aa a tuberculostatic agent than any other known 
substance whether synthetic or antiblotleo
Bernstein*0, studlng the ohemothen$y of experimental 
tuberculosis in mice, found the minimum effeotlve dose of 
Isonlazld (V) to be one seventh hundredth of that of 
para^amlnosallcylic aoid0
Prom the earlier Investigation on tuberoulostats of 
the pyridine series. It seemed likely that positional and 
structural changes in lsonlcotlnlc acid hydrazlde would 
result in dlminitlon or abolition of aotivlty« This was 
substantiated when ploollnic a d d  hydrazlde (XXI) and 
nicotinic a d d  hydrazlde (XIII) were examlnedo
Q —
(XII)
The former was found to be active but very toxic whilst 
the latter was found to be devoid of.activity* The 
addition of another acid hydrazlde group In the p »
(XXIX)
9p
position of 2, 6 - dimethyl nicotinic acid hydrazlde 
also produced an Inactive compound (XXV)«
It was, therefore, apparent that theV- position was the
amino^hydrogOn atom of the hydraslno group by a 
benzenesulphonyl group also resulted In the production of 
compounds (XV) devoid of tuberculosis activity o
The effect of substituting a benzene for a pyridine 
ring was studied by preparing a series of benzoic acid 
hydrazidee3-2 with subsltuents in the ortho«, meta« and 
para- positions0 These compounds proved to be inactiveo 
However Mndzhoyan, Afrikyan and Organesjan3*^ have recently 
prepared a number of bsasylalkylamlno«acethydrazidos of 
general formula (XVI, R~Me or Etj R^jte, Et„ n-J?r, n-Bu) 
which are claimed to be tuberculostatic0
GO~HH~2iHg
(XXV)
position of choice3,3,0 Any attempt to replace an
(XV)
lOo
R“N-*CHgo=CO“NH'-NHg
(XVI)
The effect of replacing the amino-hydrogen atoms of the 
hydrazlno moiety by a phosphorus atom has been studied 
and compounds with the general formula Asp =CONH~N®P~NH~BHCG&? J  
have been prepared**0 These compounds have also been claimed 
to be potent tuberculostatsQ
Recently compounds with the general structure (XVII) 
(R®acyl) have also been preparedo Of these compounds ,
2 - isonicotinylhydrazino-5-nitroso tropone (XVII; R^4~0GC6H4N)
»l t;
was found to be an active tuberculostato
(XVII)
To determine the effect of substitution on the 
hydrazine moiety, two compounds, lp2~dllsonlcotinyi 
hydrazine (XVIII) and l°isonicotlnyl<»2^D«gluo08yl hydrazine
(XIX), (a or b) were preparedo Both showed high 
antltubercular activity, the latter being more active and 
less toxic in mice than the parent compoundo
(XVIII)
0<Mra«HeCH« (CHOH )4«CHE0H
(XIX a)
OH
Ehe high activity of the latter prompted investigation 
of alkylldene derivatives in the hope of revealing 
superior tuberculostats and determining^ if possibles the 
structural limits of activity » As a result Pox and 
GIbas 3-6 * 17 j, 18 some twenty alkylldene derivatives 
(XX) of laonlootlnic add hydrazlde by condensation with 
aldehydes and ketones 0
oo-kh«h«c kS
O
(XX)
All were active, and the In vivo activity of several was
12 o
greater than any known synthetic tuberculostat except 
thpt of the parent compound (V)G With the exception of 
the alloxan derivative (XX; RRs ) all were readily
hydrolyaahleo In addition some sugar derivatives were 
also prepared and studied for in vivo activity in 
infected mlce« They also were very active and relatively 
leas toxic***«,
Since scission of the Schlff*a base linkage took 
place even In the solid state9 it was decided to eliminate 
the double bond by hydrogenating the alkylldene derivatives*^* ^  
under mild conditions„
0~HH~H®CRR
*VHs >
40«S0 PoSof
0~HH~HH~CHRR
All the alkyl and most of the oyolo«alkyl and 
aralkyl derivatives were found to be aotlve tuberoulostats* 
When complete reduction of the ring was carried out the 
resulting compound showed no activity at alio The 
replacement of the imino hydrogen in the hydrazlde moiety 
by alkyl groups gave compounds ~ less aotlve than
their counterparts with alkyl substituent on the terminal 
nltrogenb
The fact that l02-dlisonicotinyl hydrazine has been
shown to be an active tuberculostatic in vivo Indicated
3L3c
that acyl derivatives might show tuberculostatic activity© 
Therefore* a series of rnono^acyl and diacyl derivatives8** 
of isonicotinic acid hydrazlde were prepared by the action 
of the appropriate a d d  chloride or add anhydride on the 
parent compound 0 The phthalyl derivative could be 
obtained similarly from isonicotinyl hydrazlde and 
phthallo anhydride to give l-(Isonicotinyl -hydroxy
eerbonylbehBeyl ) hydrazine (XXXI) which then cyolised to 
give l~l8onlcotinyl~2~phthalyl hydrazine (XXXXa) by 
heating at 20G~210°C 0
(XXII >
(XXIIa)
Kakimoto and Yamamoto84 prepared and examined a 
series of hydrazones (XXIII) by condensing the three 
isomeric pyridine oarboxylle acid hydrazides with the three
Isomeric pyridine aldehydes© These derivatives showed high
In vivo activity and were claimed to be superior even to 
that of lsonicotlnlc acid hydrazlde0
(XXIII)
Salkohlj, Aramaki and Achl^® prepared the 5^nItro 
furfurylidene derivatives (XXIV) by condensing 5« 
nltrofurfuraldehyde with the three isomeric pyridine 
carboxylic acid hydrazldes0 These compounds were also 
found to possess high tuberculostatic activity*.
o2„ - O ch^  rs ( ^ ^ - c o-nh~h 8
(XXIV)
Since the structux*e»activity investigation of 
lsonicotlnlc acid hydrazlde suggested the possibility of 
tuberculostatic properties in a wide range of structure & 
Pox and oibas^® carried out the preparation of a series of 
dlalkyl derivatives0 Two types were possible9 one In 
which both hydrogen atoms on the terminal nitrogen were 
replaced by alkyl groupsor by a cyclic structurep and the 
other In which one hydrogen on each hydrazlde nitrogen was
15 o
replaced by an alkyl or equivalent group• Compounds of 
the first type were prepared by condensing lsonlootlnyl 
chloride hydrochloride with the appropriate unsymmetrlesl^ 
hydrazine In the presence of pyridine o The second type 
were prepared by treating l«l8onlcotinyl-2~alkylhydrazines 
with the appropriate alkyl halide In the presence of sodium 
ethoxldCe l~IsoniootInyl»3 p6~dimethyl pyrazole (XXV) was 
prepared by condensing Isonlcotlnyl chloride hydrochloride 
with 3,5«dlinethyl pyrazole In the presence of pyridine or 
alternatively from lsonicotlnlc acid hydrazlde and 
acetylaoetone o
Most of the compounds of the first type were found 
to possess tuberculostatic activityp probably beoause these 
compounds, like alkylldene p phthalyl and dlaoyl derivatives 
of iaonleotlnio a d d  hydrazlde 9 also have both the hydrogens 
on the terminal nitrogen atom replaced by substituent groups 0 
However compounds of the second type showed much reduced 
activity and l~Isonicbtl»yi~3p5~dImethyl pyrazole in which all 
the three hydrazine hydrogens are replaced was inactive o 
It was expected that N^N®N^trialteyl derivatives®® would
(XXV)
16 o
therefore he inactive* and* as anticipated* they were found 
to he either Inactive or weakly aotlve in mice infected with 
Mycobacterium tuberculosis Q
A similar Investigation was undertaken by 
Oymerman*Craig ana Willis29, who prepared H N^dlmethyl ~ 
J H 1* dilsonlcotinyl hydrasins (XXVI), H-methyl»H= 
iaonlootlnyl hydrasins (XXVII), and its bensylldsne 
derivative (XXVIII)0 All were devoid of tuberculostatic 
activitya
Further modification of the acid hydraside moiety was
oxygen function hy sulphur* Among the compounds tested 
against tuheroulosls were thlolsonicotinio a dd hydrazlde 
and its hensylidene and salloylldene derivatives * 
Tuheroulosls activity was greatly diminished compared with 
isonicotinic acid hydrazlde P
In order todstermine the effect of separating the acid 
hydrazlde moiety from the pyridine nucleus* Katritzky33*
(XXVI)
(XXVII)
OaC-ll<=KBCH-C6H5
(XXVIII)
carried out by Stalg, Slefkin and Offtfe"* by replacing the
!7o
prepared 4*>pyridylaoethydrazide (XXIX ) * p«4«pyridyX 
proplotdiydr&dde (XXX)* and p~4«pyridyl aorylbydraslde 
(XXXI) from the corresponding esters» These compounds
showed no activity In tuberculosis infected mlce0 It* 
however, indicated that the atfeshment of the » CO-NH-HHg 
group to a pyridine nucleus la a necessary requirement for 
antltuberoulo8l3 activityQ
(XXIX)
(XXXI)
The effect of separating the a d d  hydraslde group 
from the pyridine nucleus by a thlomethylene group was 
Investigated by Japanese workers^2, who prepared 
<*C «> (4-pyrldylthio) acethydrazide (XXXII g R e f t * ® h ) and its 
lsopropylldene derivative (XXXIIg R R^:C 3£eg)» These were 
also inactive o
(XXXII)
180
The high activity of Isonlazld and ita derivatives 
encouraged Investigation of other heterocyclic systems330 
The most active compounds were 2«furolc add hydrazlde 
(XXXIII), thle phene-2=c arboxyllc acid hydrazlde (XXXIV )p and 
Imidazole *>4 (5) ~ oarboxyllc add hydrazlde (XXXV )c
Mycobacterium tuberculosis q While several of these 
hydrasIdes showed slight activity in vivo» none appeared to 
warrant further Invest!gatlonc Quite recently some
oxazolone, thlazolldlnep plperidone p Indolyl and 1mldasolone 
acid hydrazides37f)38 have been prepared and It Is claimed they 
are potential tuberculostatic agent0 Although heterocyclic 
acid hydrazldes, in general 9 did not show any promise p
pyrazinamlde has proved to be highly active« Pyr as inamide 
(XXXVI) which Is Isos ter io with nicotinamide was synthesized 
by Kushner and his associates^©0 Early reports on Its
(XXXIII)
K
(XXXIV) (XXXV)
In addition aoid hydrazldee of various other 
heterooyolla systems, e„g„, pyrrole, pyrimidine end 
pyraslne®*»®®»®® vero also prepared and examined against ■
190
in vivo activity wore conflicting* Marked variation of 
activity was apparent from one culture medium to another* 
hut Tompsett and his associates40 showed that pyrazinamide 
was a potentially useful drug*
The first chemical trial of pyrazinamide conducted toy
anti tubercular but its effect was not sustained and 
resistance developed rapidly□ The drug*a hepato-fcoxioity 
has discouraged Its clinical use* However combined with 
Streptomycin or with Ison!asId it may have particular value* 
enhancing activity, and delaying onset of resistance to the 
drug with which It is combined*
Investigation of non«pyrldlnold add hydrazldes 
was carried out by Pox20, and by Bernstein42, who prepared 
a number of chloro», hydroxy- and amlno-benzolo add 
hydrazldes but none was active* However Buu-Hol40 and 
his ooworkers have shown that 5-substituted salicylic add 
hydrazldes (XXXVII g XsGl^Br) and 2-hydroxy naphthoic acid 
hydrazlde (XXXVIII) were antltubercularo Misaki44 has 
claimed that pHminosalicyllo acid hydrazlde (XXXIX) has 
greater activity than p~aminosalleylie acid (PAS) (XL), but
(XXXVI)
Yeager and his associates41 showed that it was moderately
20,
Is inferior to Isoniazido
0~NH~NBg 
OH
(XXXVII)
0«NH«NH
(XXXVIII)
OH
00H
OH
NH,
(XXXIX) (XL)
Compounds35 (XLI, XLIX, XLIII) with two op more 
aromatic groups have also been prepared and found weakly 
tuberoulos tatio0
CH,
(XLII)(XLI)
21*
Few aliphatic acid hydrazldes45 are active 
tuberculostats, an exception being eyanoacetlc acid 
hydrazlde (XUV)9
OH«CH8c3co»||H«HH2
(XLIV)
Clinical trial of this compound by Schema:*5 yielded results 
which Indicated activity comparable to that of Isoniazido 
It is, however, rather toxic and, according to Bernon, 
Aulanier and Trlcoire4^, it Is two to three times more toxic 
than Isoniazido It may, however, be capable of delaying 
emergence of resistant strains in patients undergoing 
treatment with Isoniazid, Streptomycin and para«aminosallcyllc 
soldo
In vitro and in vivo studies of Isoniazid and related 
bydrazones showed that the latter were significantly less 
toxic, eego, Rubbo, Edgar and Vaughan*** prepared a series of 
hydrazones to test their relative adtlvlty in experimental 
animals« Comparison showed that veraslde (l-isonicotinyl- 
2-veratrylldenehydrazone) (XLV) exerted marked 
anti tuberculosis activity in experimentally infected guinea ^  
pigs and the acute toxicity in mice was about one third that 
of Isoniazido Similar experiments carried out by other 
investigators*** has confirmed thiso
OCH3
(XLV)
Since Isoniazid has a marked tendency to form chelate 
compounds, It was thought that chelation with divalent 
metals might he an essential prerequisite determining the 
antltuberoulosis activity of Isoniazid and verazlde«
In order to test this assumption, the iron, cohalt, zinc 
and copper complexes of Isoniazid <XI»VX,a) and verazide 
(XLVI,b) were prepared and tested for antltuberoulosis 
activity*8* The results of these tests showed that the 
activity of all the metal complexes was equal to that of 
the unoomplexed drug* It did not appear therefore that 
the role of the potentiator (or antagonlzer) of Isoniazid 
could he assigned to any of the metals examined0
(XLVXa) (XLVIb)
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The effect of replacing a hydrogen atom of the 
primary nitrogen of the isomeric pyridine carboxylie acid 
hydrazldes by a p-acetamidobenzenesulphonyl group was studiedj 
by Dornow and Wedekind®^, but these compounds (XLVII) were j
Several aromatic a&Xphoftylhydrazides were also 
prepared and subjected to in vivo and in vitro examinations 
but were found to be devoid of activityo
To Investigate th£ effect on antituberculosis activity 
of replacing the carbonyl by asdphonyl group, Talik and 
Plazek^, and Comrie and Stenlake®^, synthesized some 
pyridine-2, and pyridine~4~sulphonhydrazides (XLVHI,a&b) 
and their derivatives but none showed any significant 
activity against Mycobacterium tuberculosis a
inactive *
Ac«p
HB~C 6H4~S02~M-NJM30
(XLVII)
(XLVIIIa) (XLVIIIb)
The effect on the antituberoulosis activity of 
quateroizing the ring nitrogen of Isoniazid was studied by 
Yale and his ooworkera4^, who showed that the compound (XUX) 
had lower activity than lsonlootinio acid hydrazlde«
(XldX)
Again to determine the effect of modifying the ring 
nitrogen function on the tuberculosis activity, Yale 
prepared isonicotlnlo add hydrazlde «* 1 « oxide (X»)0 
This compound, however, was found to be leas active than 
Isoniazid*
4r
A similar investigation was carried out hy workers64 in
5 V ' *
Poland, who prepared 2-hydrazinoisonioptinyl hydrazine (II) 
and its N-oxide (LII) 0 These compounds have been found to
be only weekly tuberculostatic*
0
(LI) (LII)
The high activity of thiolsonicotlnamlde (LIII) in 
experimental tuberculosis prompted Gardner* Wenis and
compounds were either inactive or less active than 
thiolsonicotlnamlde o
During an attempt to obtain tuberoulostats more 
potent than thiolsonicotlnamlde* alkyl derivatives of this 
drug were prepared and examined an&2~ethyl thiolsonicotlnamlde 
(LVI) proved to be an active tuberculostato This compound 
was first synthesized by Llbermann and the biological studies 
were carried out by Rist* Grumbaoh* Moyeux* Gals* Roualx
CONE
CSNH
0
(LV)
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and Clavel^o High in vivo and in vitro activity 
against Isoniazid resistant stains of Hyoobact^mw 
tuberculosis encouraged its clinical use®8*
c s m
(LVI)
The effect of replacing the carbonyl group in 
isonicotinic acid hydrazlde«l«oxlde by a sulphonyl group 
was studied by Angulo and Munio&S9, who prepared pyridine 
sulphonhydraside=l«C3cld6» (LVII) and some Of Its 
derivatives (LVXII)*
SOo-KH-HsCRHo
0
(l v h i )
All these compounds were found to be either inactive or 
less active than Isonicotinic acid hydraslde*
Og-NH^NHg
(LVII)
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MODE OP ACTION OF ANTITUBERCULOSIS AGENT
At present there is no established mechanism to explain 
the activity of any anti tuberculous agent, although a number 
of hypotheses have been advaneedo One of the most widely 
advocated, postulates that antitubereulous activity of 
compounds sush as the thlosemlcarbazidas, the thioureas p 
hydroxamic adds, p -f>n»i^ acaalicylic acid, pyridine 
carboxyllc acid hydrazldes and their derivatives9is 
associated with their ability to form stable complexes with 
metals such as copper and iron which may be essential for 
the metabolic processes of the tubercle bacillus?0*61,62,65 
Bergel has postulated that copper and iron are 
"pro^oxldants”, which act by catalysing the auto«oxldatlon 
of lipids« When copper and iron form chelates with drugs , 
this bole is inhibited» Thus he assumed that the 
antitubereulous activity of a compound is a function of its 
anti-oxidant activityo
The chelation hypothesis falls to explain the Inactivity 
of nicotinic acid hydrazlde although it is as effeotlve as 
Isoniazid as a chelating agent640 Pox and Gibas28 have, 
however, shown that at least in one case chelating ability 
is not essential for antitubereulous activity among' acid 
hydrazldes p by examining l~isonicotinyl«l<*isopropyl biydrazine 
(LIX) which, though strongly tuberculostatic, does not fora 
a copper chelatec.
26c
CH(CH3J2
(LIX)
Continuing possible correlation between antitubereulous 
activity and chelating ability, Cymeraan-Cralg and Willis29 
prepared N'bj2 -dimethyl-N1!}2- dlisonlootlnyl hydrazine (XXVI) 
and the benzylidene derivative of N1-methyl-N1-,iaoniootinyX 
hydrazine (XXVIII)© Both compounds were inaotlve and since 
they are Incapable of chelation via a pseudo-acid and give 
neither a colour change nor a precipitate with cuprio ions 
they concluded that a direct connection between chelating 
ability and antitubereulous activity might exist© The 
evidence Is therefor© conflicting© Another hypothesis tc
explain a drug-tubercle relationship postulates that the 
drug interferes with tubercle enzymes© Pop§6and Yorida66 
have shown that a number of metabolites of possible 
significance antagonized the action of Isoniazid© Of these 
pyridoxin© (LX) was the most effective 9 and there were reasons 
for believing that essential enzyme systems of the tubercle 
bacilli containing pyrldoxal phosphate as a vital component 
are inhibited by Isoniazid© Pyrido&al containing enzymes 
play a prominent role in decarboxylation^transamination and 
other reactions of amino-acid metabolism© -Kefcoglutaric 
a d d  also inhibited the action of Isoniazid© Barclay and his 
co have shown that tubercle bacilli sensitive to
Isoniazid fixed the drug firmly© Thus it Is assumed that
290
after up-take of the drug by the tubercle bacilli normal 
enzyme activity was hindered** A decrease in the pyridine 
nucleotide level in tuberculosis Infected animals, and 
subsequent return to normal after the administration of 
Isoniazid, led Patiala®® to suggest that Isoniazid 
inhibited enzymatic reactions in which pyridine nucleotides 
are involved; this is probably due to the structural 
similarity of nicotinamide and Isoniazid which replaces 
nicotinamide in the pyridine nucleotide to produce a 
biologically Inaotlve compoundo Goldman**9 has Isolated the 
Isoniazid nucleotide analogue of diphosphopyrldine 
nucleotide (DPN) o
OH
CH.
(LX)
Modification In anabolic activity and reduction In 
lipid synthesis have also been observedo All these 
changes show that after treatment with Isoniazid loss of 
enzymatic activity ensues o
The possibility that antibacterial activity of the drug 
may be due to its ability to modify surface tension has also 
been advanced in the case of surface active agents such as 
polyoxyethylene ethers70* The idea is supported by the
observation that these substances depress tuberoulln 
sensitivity In guinea^plg^ and stimulate macrophages to
'SQo
kill or inhibit growth in th© macrophages which h a w  not 
been exposed to the surface active agents7^
MQNO-AMXHE OKIDASE INHIBITORS (UkOlJi
During the search for more potent tuberculostats 9 
Pox and Gibas prepared a large number of l-alkyl~2- 
isonlootlnyX hydrazin© derivatives, one of these being 
l-Isopropyl-2«lsonlcotinyl hydrazine (LX1)0
(UI)
On clinical investigation?3p this compound, showed,marked 
central nervous activity, manifested in an improvement of 
appetite and mental attitude o Simultaneously with these
clinical findings, the powerful mono-amine oxidase 
inhibiting effect of Iproniazid was demonstrated by Seller 
and his associates74*75**^ s77 and this led to the synthesis 
and examination of a large number of hydras in© derivatives Q 
The biological examination of alkyl hydrasines revealed that 
activity was greatest with alkyl substituents with two to 
four carbon atoms; Increase in the number of carbon atoms 3L©ci 
to a decrease in activity which was negligible above eight
31,
78 70
carbon atoms * 0 The replacement of an alkyl group In an
alkyl hydrazine by an aromatic or heteroaromatlc group88*8 *^ 
often resulted in a loss of antidepressant activity*?
However in most cases areJ^yl hydrazines®***>8® proved to be 
effective, e0g«, p~phenylethyl hydrazine (LXII)(Phenelzine) 
and p-phenylisopropyl hydrazine (DCIII) are efficient 
mono~amine oxidase inhibitors which have been used 
clinically as antidepressants«
HgcCHg-KH-NHg
?HS
Cij^CH-NH-NHj
(IXXX) (IX III)
PhenyIIsopropyl hydrazine is twice as active by the 
lntra«perltoneal route as by the oral route and its action 
Is prolonged* Stereo specificity®^®® was also observed
In these substances, e0ge, the optical isomer of 
J3«phenyllsopropyl hydrazine which corresponds to 
D^amphetamine is effective in vivo and in vitroo
The study of symmetrical dialkyi hydrazines86 showed 
that they are not generally efficient Inhibitors in vivo0 
Nevertheless with suitable alkyl or aralkyl groups strong 
mono«amine oxidase inhibitors were obtained, e ©go s 1,2,~ 
dilsopropyl hydrazine (LXIV) exhibits an effect equivalent 
to that of Isopropyl hydrazine*
(CHg )g;CH=NH=NH0CB * CE& )e 
(LXIV)
{0% >gCH-NH~HH~CH2f!6Ha 
(IXV)
S ~Benayl«=>H®=laopropyl hydrazine (LXV) la Inactive In vitro
but active In vivo and is four times as active 
lntraperltoneally as orally*, The onset of action of
N*cbenzyl»22 ~lsopropyl hydrazine Is fairly rapid and Its 
activity decreased four hours after admlnlstratlono
The structure«activity relationship of hydrazldes showed 
that by selective aoylation8^®88 of alkyl hydrazldes it was 
possible to achieve control over biological potency and 
distribution of these compounds in the body® The alkyl 
group in alkyl hydrazldes played a prominent role in 
detenainlj&g the JiAOI activity, ecgo, the activity rises to a 
maximum at three to four carbon atoms and declines markedly 
at seven to nine carbon atoms?® Aralkyl hydrazldes often 
showed higher activity than the corresponding alkyl 
hydrazldes, but the aryl hydrazldes were found to be inactiveQ 
Acylation of alkyl or aralkyl hydrazldes at the nitrogen atom 
which already carried an alkyl or aralkyl group always led to 
decrease in antidepressant activity,, The Introduction of a 
second alkyl group In the hydrazine moiety of alkyl hydrazldes
led to two types of derivative,, namely* N^N^dialkyl 
derivatives (IXVI) and N2~dialkyl derivatives (LXVII)0
R-C0-NJH-Ik ROO»HH«Nc=R
i i V
(Ixvi) (IXVXI)
It was noted that active H^-dialkyl hydrazldes could he 
obtained from weakly active Ne~monoalkyl hydrazldes by 
Introducing a second alkyl group; the introduction of a 
second alkyl group as In compound (LXVII) failed to effect 
Improvement a This relationship has been confirmed in the 
case of the isopropyl group0
Compound Activity index
R*H* R»Hf R ^ H  m»2 100
R®CH3£egs R^Rj R°CHl&e£ 174
RsCTOeg; R«*®H 66
R®H; R®R®CMe2 88
The diaralkyl hydrazldes have not been thoroughly Investigated, 
hence generalization concerning sfcructure^actlvity 
relationships is not possible 0 Diaoyl hydrazldes also 
showed MAOI activity®^
Whilst many aliphatic* arylaliphatlc and 
cycloaliphatic hydrazldes have been synthesized and 
examined* no relatable pattern of structure to activity 
has been dlscoveredo The higher fatty acid hydrazldes are 
generally less effective* this being attributed to 
diminished solubility, e.g., g2=lsopropyl stearic sold 
hydrazlde (LJCVXII) Is devoid of MAOI activity.
CHg- (CHg) 16C0-NH=KH=CH= (CH3 )g 
(LXVIII)
Aliphatic hydrazldes with branching on the cC or p-carbon 
Invariably showed less activity th^n the corresponding 
unbranched derivatives* and unsaturated acid hydrazldes
were more effective than saturated acid hydrazldes0
89Aromatic and heteroaromatlo acid hydrazldes 
usually showed MAOI activity* The introduction of 
substituents in many cases was unfavourable with respect 
to activity* Aromatic acid hydrazldes with a free 
phenolic group were less active e 0g0, compound (LXXX) 
is an active mono-amine oxidase inhibitor but the 
replacement of the chlorine atom by a hydroxyl group 
(oompouna EXX) abolishes activity®9
35 o
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Pyrimidine jyyrazlne and pyrldazlne earboxyllc acid 
hydrazldes , generally^ yielded potent xaono^amlne oxidase 
Inhibitors o Among the isoxazole carboxyllo acid 
hydrazldes, 5-methyl isoxazole-3-carbbxylic acid 
hydrazlde (LXXI) has been found to possess the highest 
MAOI activityo
(LKXI)
Recently Xsocarboxazole (UtXII) was found to be a
QA
potential antidepressant and la now In ollnioal usee
O-HH-NH* CHg^C^Hg
(UtXII)
Sulphonatlon of benzyl hydrazine with an aromatic 
or an aliphatic sulphonyl chloride gave sulphonyl 
hydrazldes with good mono-amine oxidase Inhibiting 
activityo The N*«fcenzyl sulphonyl hydrazlde (LXXIII) 
showed specially high actlvlty0
(IXXIII)
MODE OP ACTION OP MOHO-AMIKE OXIDASE INHIBITORS
Antidepressant drugs can be divided Into three groups:
(1) the mono-amine oxidase inhibitors (2) Imipramlne
(LX.XIV) and related compounds and (3) amphetamine (LXXV)
like substanceso Much of the present day theory depends
/v
upon the acceptance of the physiological role In the brain
91of the chemical transmitter substances 9 notably 
sympathln which Is a mixture of adrenaline (IXXYI), and 
noradrenaline (IXXVII), dopamine (IXXVIII) and 
5~hydroxytryptamine (LXXIX) o
Og-N-HHg
CHg«CgHg
IH2~CH2~N(lffe )2(XXXXV)
NIL
(IXXV)
Hg^C&^NHg
(LXXVXIX)
.OH
OH
CHQH<-C%NH«CH3
(IXXVX)
cm
(LXXVII)
HO
5~Hydroxy trypt amine and tryptamlne are believed to be 
derived from tryptophan and dopamine and nor«adrenaline 
from tyrosine, and aot mainly on the sub-cortlcal region 
of tbs braino It has been shown that relatively large 
amounts of these amines are concentrated In the 
hypothalamus and other cortical regions of the braln<> 
Their chief action is excitation; under the effect of 
nervous stimuli these substances are liberated at the
receptor sites In the cells0 They are not allowed to 
accumulate at these sites but are oxidised to inaotlve 
compounds by mono»amine oxidase which thus prevents their 
accumulation*, Many of the antidepressants have been shown 
to inhibit the action of mono»amlne oxidase and are 
described collectively as raono»amlne oxidase Inhibitors o 
Since one of the function of this enzyme is concerned with 
lnaotlvlatlon of 5-hydroxytrypt amine and perhaps also 
of noradrenaline, drugs which Impair its activity in any 
way will interfere with metabolism of 5-hydroxytryptamine 
and the other amines o This causes the amines to 
accumulate and leads to exaggerated action^ For this 
reason the characteristic effect of the antidepressants 
upon the mood of the depressed person, has been suggested 
to be due to the accumulation in the brain of the 
catecholamines92*93 (noradrenaline, adrenaline, dopamine or 
5«hydro^.ytryptamlne) o A number of other potent 
antidepressant drugs have also been shown to Inhibit 
enzymes« However, there are drugs which are effective 
antidepressants but whloh do not Inhibit mono~amlne oxidase 
6og«» Imlpramlne and orphenadrlne (jJckX)«
(CH3  )gcoN«CHg®CHg«0 ->C 
(LXXX}
39o
On the other hand the antihistaminic diphenhydramine 
(LXXXI) is a mono-amine oxidase inhibitor but does not 
exert antidepressant effects„ These facts are difficult 
to explain and it is possible that the antidepressant 
drugs and other central nervous stimulants, e«»g«, the 
amphetamine!* *exert their effect primarily by increasing 
the level of energy-yielding compounds in the braln0
CH«0~CHg~CHg-N (CHg )g
(LXXXI)
All the antidepressants drugs have aide^effects?^”®6 
Several reactions during therapy are due to individual 
susceptibility or to Incompatibility with certain 
exogenous substances D The main slde^effects are 
prolonged hypertension and over-stimulation which 
results in agitation and excitement» Withdrawal
symptoms may start after two or three days and may last 
for several weeks« These symptoms Include headache p 
dreaming* irritability* dizziness, Insomnia and somnolence o 
Sexual function may be disturbed in different ways 
dependlwg very much on individual susceptibilitya 
Muscle jerking, tremors, fits and peripheral neuritis
40o
have also been reported in susceptible Individuals»
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Prom the widely differing nature of current clinical 
tuberculostats It would appear that there are a few 
specific chemical structures which can be associated with 
tuberculostatic activity, and, within each group provided 
structural variation is not too radical, It is possible 
to prepare derivatives in which activity Is retainedo 
Thus among the pyridine carboxylic acid hydrazldes 
structural variation with retention of activity was 
confined to the hydrazide moiety of the molecule, and 
further the©c~ andY« positions were the ones of choice0 
This structural activity pattern led to the synthesis 
and examination of a large number of pyridine-2 and -4 
carboxylic acid hydrazlde derivatives0
A number of aliphatic acid hydrazldes, arylaliphatle 
hydrazldes, aromatic acid hydrazldes, carbocyclie acid 
hydrazldes and other heterocyclic hydrazldes have been 
prepared and examined for antituberculosis aciS^f 
The study of these acid hydrazldes showed that the 
aliphatic hydrazldes were often devoid of activity and 
that aryl hydrazldes lacking an amino or hydrosyl group 
possessed significant actlvityo Talik and Plazek*?2 
have shown that l»lsopropyliden6~2^pyridIne«1iN&uXphonyl) 
hydrazine was tuberculostatic, but they failed to 
isolate and examine the parent substance*. Comrie and 
Stenlake^3 also found that some of the derivatives of 
pyrIdIn©»4~sulphonhydrazide were very weakly tuberculostati
42 c,
In view of the tuberculostatic activity of l-Isopropylldene-2—
/
(pyridlne«2 ~sulphony!l) hydrazine, it was decided to prepare 
pyridIne -2 -aulphonhydraz 1  de and pyrldlne-2 —sulphonhydrazIde-
1 -oxide and ..Itte derivatives« This course of study was 
also encouraged by the observation of Steinberg^ and his 
co-workers who have shown that In general the N-oxides of 
isonlcotinlc acid and picolinlc acid hydrazlde were active 
and less toxic than most of their other derivativeso 
Furthermore Angulo and MuniclS^ also showed that pyridine— 
4-sulphonhydrazlde-l-oxlde and its derivatives were more 
active than the corresponding pyrldine-4-sulphonhydrazide 
and its derivativeso
Separation of the pyridine nucleus from the hydrasIde 
moiety in isonlcotinlc acid hydrazlde by a thiomethylene 
group Indicated that the resulting compounds were less 
tuberculostatic than Isoniazld? 2  It was, however, planned 
to examine the effect of separating the acid hydrazlde 
moiety from the pyridine nucleus in picolinlc acid hydrazlde 
and its N-oxidCo Four lines of Investigation were 
envisaged:
lo The synthesis of pyrldlne-2 -sulphonhydrazideo 
2o The synthesis of pyrIdine-2 -sulphonhydrazide-l-oxlde 
and Its derivativeso 
3 0 The synthesis of•C-(2 -pyrldylthlo) acethydrazide and
its derivativeso 
4o The synthesis of <>( 2 «pyridylthlo)acethydrazlde=l« 
oxide and Its derivativeso
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2~Bromopyridine was obtained in quantitative yield 
by the method described by Allen and Thirtle*01 but 
oxidation of 2-bromopyridine to 2-bromopyrIdIn©-X<*>oxide 
was unsuccessfulo Bernstein and his co-workers102 
obtained the latter compound In good yield using peracetic 
acid as the oxidising agent, but repetition of this method 
gave Instead white crystalline material which was not 
homogenous but decomposed over the rang© of 20° and had 
none of the properties of the required compound0 It was 
hygroscopic, developed a pyridine-like smell after some tisa# 
and failed to react with thiourea or form a mercury complex© 
Oxidation with perbenzole acid however gave 2- 
bromopyridine-1-oxide in the reported yieldo If the 
mixture of perbenzoie acid and 2-bromopyridine In 
chloroform was kept at room temperature for seven days 
instead of five days as In the method described by 
Bernstein the yield of 2~bromopyrIdIne-l=oxId© was 
Increasedo Conversion of 2-bromopyrIdIne-l-oxide into 
2-mercaptopyrldine-1-oxide was carried out by the method 
described by Bernstein and Shaw-^2e hut the literature 
yield could not be reproduced0 The conversion of 
2-bromopyridine Into 2-mercaptopyrldine with thiourea was
103carried out by the method described by Phillip and Shapiro© 
PREPARATION OF PYRIDINE-2-SULPH0NYL CHLORIDE o
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The difficulty in synthesizing pyridine and quinoline^ 
2=and -4-sulphonyl chlorides from the corresponding
sulphonlc acid or its sodium salt, and thlonyl chloride*, 
phosphorus pentachlorlde, ohlorosulphonic acid or 
benzotrichloride has been reported by King and Ware} 0 4  
CaMifelX and Kornfeld1 0 8  and by Kwart and Miller} 0 6  and 
probably results from the elevated temperature necessary for 
the transformation, exceeding that of the thermal 
stability of the sulphonyl chloride® Prom the nature of 
the products Isolated it appears that a combined 
desulphonatlon and nucleophllio replacement takes place©
The mechanism of scission of the carbon to sulphur bond 
has been postulated by Kwart and Miller to take place as 
follows?
In the case of the corresponding pyridine derivatives the 
relatively unstable 4 -chloropyridine Is formed which 
undergoes a process of self^oondensationo The nature of 
the products formed depends upon their method of Isolation?
This difficulty has been overcome by -the low temperature 
chlorination of the parent mere apt an under acid conditions 0 
, ATTEMPTED SYNTHESIS OF PYRXDXHE^g^SULPHONHyDRAZXDE 0
Pyridlne-2-sulphonyl chloride was prepared by the 
chlorination of 2 -mercaptopyridine in hydrochloric acid 
at low temperature and isolated by neutralizing and 
extracting into chloroform* When the chloroform solution 
was poured into cold hydrazine hydrate (2 moles) the
4 7o
mixture became slightly warmer and gummy material 
separated outo Attemps to purify the product drastically 
reduced the yieldo The white solid which was obtained 
only in milligram amounts evolved sulphur dioxide when its 
aqueous solution was gtf&snetio Extracting the sulphonyl 
chloride into methylene chloride1 < ? 6 instead of chloroform 
failed to increase the yield and varying the experimental 
conditions was also unsuccessfulP Since sulphonamides 
are more stable and more easily prepared than 
sulphonhydrazides, preparation of pyridine~2 ~sulphonamide 
was attempted to show the formation of sulphonyl chloride 
but again a poor yield was obtained,, probably as a 
result of desulphonatlon0
While the preparation of pyridine -2-sulphonamlde 
and 2~sulphonhydrazide from 2-mercaptopyridine had been 
unsatisfactoryp a parallel series of experiments with 
S^mercaptopyrldine^l^oxide was more satisfactoryo 
Chlorination took place readily and on passing a dry
PYRIDINE~2^SULFH0I?YL CHhQRIDB~l~QXIDB 0
stream of ammonia into a chloroform solution of the 
sulphonyl chlorlde«l~oxlde 9 pyridine =>2 ~sulphonamide^l«oxld© 
identical with the product obtained from the peracetic acid 
oxidation of pyridine~2 ~sulphonamid© 1 0 7  was obtalnedo 
The greater stability of pyrldine~2 ~3 ulphonyl chloride 
~l»oxide is probably due to electron release from the 
N~oxlde to the nucleus increasing electron density at the 
cC and Y-positions* and thus inhibiting the desulphonation 
and nucleophilic replacement which takes place readily in 
the deoxygenated parent compoundo
II
0
PYRIDINE~2~StlLPH0NHYDRAZIDE IDE AND ITS DERIVATIVES 0
Prom the ease with which the sulphonamide~l~oxlde 
was obtained it was expected that the sulphonhydrazlde 
oxide would be obtained by the treatment of the sulphonyl 
ohloride»l-oxide with hydrazine hydrate« Accordingly the 
chloroform solution was added in small portions to 
hydrazine hydrateo A mixture of the product and hydrazine 
hydrochloride was obtained corresponding to an overall yield 
in the region of 50$p but recovery of pyridine 
sulphonhydrazlde-l-oxide was less than 10%o A somewhat 
less pure product (moPoSS®) could* however9 be obtained in
m —
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about 3,5$ yield by carefully suspending the product in, 
and washing wlth9 ice-cold water<> This was sufficiently 
pure for most of the subsequent syntheses undertakeno 
This product reduced aramonieal silver nitrate in the cold 
and was sparingly soluble In water9 methanol and ethanol 
from which it could be crystallized by caustiously warning 
to effect soXutIono Attempts to Improve the yield by
varying the experimental conditions and method of 
separation of product from by-product met with no successos.
It is unstable and loses sulphur dioxide when warmed in 
aqueous solution., Under the same conditions the 
isomeric 4=sulphonhydraslde Is converted into pyridine 
sulphinic acid1 0 8  (LXXXII)o
SOoH
(IXXXII)
ALKYLIDENE DERIVATIVES OF PYRIDINE~2~SULPH0NHYDRAZIDE~1~ 
OXIDEoM»HNiMa«ancaa
Pyrldine-2^sulphonhydrazlde«l-oxide reacted readily 
under mild conditions with aromatic aldehydes to give 
sulphonhydrazones«
50o
The general method used involved suspension of pyridine- 
2-sulphonhydrazide-X-oxide in methanol and adding one 
molecular proportion of the appropriate aldehyde dissolved 
in methanol© On shaking the reaction mixture the 
sulphonhydrazlde dissolved and* on leaving at room 
temperature or at 0°, the product eventually precipltatedo 
Analytically pur© samples were readily obtained by 
recrystallization from a suitable solventQ The 
yields varied from good to excellento The condensation 
of pyridlne~2«sulphorihydrazide“l~oxide with salleylaM^hyd© 
was anomolous and failed to give the expected 
sulphonhydrazoneo The physical and analytical data 
agreed well with salicylazine and this was confirmed by 
an undepressed melting point on admixture with an authentic 
sample of the azine<> It is difficult to readily 
account for the formation of salicylazine under these 
conditions and the reaction requires further Investigation 
and comparison with the reaction of other phenolic 
aldehydes with the su 1 phonhydrazIde«» 1-oxide 0
51 o
PREPARATION OP DERIVATIVES IN WHICH THE HYDRAZIDE GROUP
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IS SEPARATED FROM THE NUCLEUS 0
The effect of separating the pyridine nucleus and 
the hydrazine moiety In isonlcotinlc acid hydrazlde by 
a thiomethylene group has been shown to abolish activity*
It was of interest„ however9 to discover If the same 
effect obtained in the case of picolinlc acid hydrazlde 
which is an active but more toxic tubereulostato
ATTEMPTED SYNTHESIS OP N~ (g~PXRIDYLTHIQ ,v
Condensation of 2«mercaptopyridin© and ethyl
chloroformate was carried out In cold ethanol0 The
cream-coloured solid which had a fruity smell and was
hygroscopic 9 was refluxed with anhydrous hydrazine
(Smole) in dry ethanol0 Removal of the solvent gave a
viscous oil which failed to crystallize0 The oil was
extracted with ether till the ether extract was colourless 0
On concentrating the ^ther9 a yellow solid crystallised
outo A mixed melting point with 2«mercaptopyrIdlne did
not show any depression© It therefor© seemed that
hydrasinolysis of the ester had taken place© An analogous
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reaction sequence has been reported with 4«mercaptopyridine0 
Attempts to prepare the desired compound by modifying the 
experimental conditions were unsuccessful© The synthesis 
ofU pyridyIthio 0SiAlft'L ill©!-!.
considered©
oC <* ( 2~ PYRIDYLTHX 0
Tli© Interaction of 2-mercaptopyridine°l~oxIde and 
ethyl bromoacetate on refluxing in aqueous solution gave 
a crystalline product which failed to analyse for the 
expected ester? It was acid to limus its infra-red 
spectrum showed the presence of a carboxyl function and 
the elementary analysis was satisfactory for 
©C -(2-pyridythIo) acetic acld«l-oxid®0
The required ester was however obtained as Its 
hydrobromide whon the condesatlon was carried out in 
alcohol and when boiled with water it gave the parent 
acldo
O
# HBr 
SoCHgCOOH
I 
0
HgO 
Reflux
I HBr
0  *
S 0CH0-COOEt
Rr-OHg-GOOEt
EtOH
Reflux
H«° > 
Reflux
ARALKYLIDENE AMD ALKTLXDBHE DERIVATIVES OP o< <*, (g^FYRXDYLTKlO) 
ACET HYDRAE IDE ~I-QggDge
©C ~(2~Pyridylthio) acethydrazlde-l-oxide reacted 
readily under mild condition with aliphatic and aromatic 
aldehydes and ketones9 as well as heterocyclic carbonyl 
compounds? The general method Involved suspension of the 
<  <= {S-pyrldylthio) a[aethydrftSide«l“3S.S>d»j: In methanol9 
heating If necessary to effect solution and adding one 
molecular proportion of the appropriate carbonyl compound 
dissolved In methanol? On shaking the reaction mixture 
vigorously for some time and leaving it at room 
temperature9 a crystalline substance eventually separated, 
out? Analytically pure samples were obtained by 
recrystalllzEtion from a suitable solvent to conii&mat 
decomposition point ■ removing adherent solvent
In waottQp The yields varied from good to ©xeellento 
The reaction with aeetophenone was slow as might be 
expected for a ketone and the mixture had to be refluxed 
on a water~beth for one hour before the product separatedo 
On the other ha&d the reaction with acetaldehyde and 
butanal at room temperature was vigorous and gave 
seml»eolld resinous material which did not crystallize 
from the usual solvents? The reaction with glucose& 
fructose and ribose gave solids which were very hygroscopic 
and liquified even during filtration? All attempts to 
Isolate the sugar derivatives were unsuccessful?
ACYL AMD SULPHONYL DERIVATIVES QP - (2~FYR1DYLTHIQ)
ACETHYDRAZ IDE - 1-GXXDE 0TllTli —
cfC ^ (JS^Pyridylthio) acethydrazide«l«oxid© reacted 
smoothly with acid chlorides, acid anhydrides and 
sulphonyl chlorides giving well-defined crystalline 
derivatives in good yields according to the following 
scheme 0
^ - S C H 2 «G0 -M«HH-C0 E
if
0
diox an 'j" (RG0 )g0
p Cl SQpOgH^o GH§
dry pyridine
RC0C1
CHg-CO-HH-MHg-
RCOOi
dry
dloxan 
S &CHg“C0~KHCTM-l*os
vS
TT S°A
0
pyridine 
CHg-C 0-HH-MH-C OR
^CRg-GO-HH-M-OOR
Toluene»p-suIphony1 chloride in dry pyridine was added 
to a suspension of»& -(2-pyridylthio
In the same solvento The^C^CS^pyridylthioJac&thydr^sid^-' -
1-oxid© dissolved, and the mixture which had turned ©rang© 
was heated for half an hour on a water«hathQ The product 
was isolated hy the addition of water and the crude product
purified by recrystalllzation from ethanolo
ACETATE-l-QXIDE WITH
HYDRQXYLAMXMEo
The required compound was prepared by interaction of 
ethyl«*6 »(2-pyridylthlo) acetate with hydroxylamine 
hydrochloride in the presence of sodium ethoxldec The 
product, obtained in moderate yield, gave a positive test 
for a hydroxamlc acido
PREPARATION DPe& -(2-FYRIDYLTHXQ) ACETHYDRAZ IBB AND ITS 
DERIVATIVES
Condensation of 2-mercaptopyridine and ethyl 
bromoacetate was carried out in ^thas&oSoThe cream coloured 
solid which had a fruity smell and was hygroscopic, was 
refluxed with hydrazine (2moles) in dry ethanol0 
Removal of the solvent gave a viscous oil which 
crystallized after some time*, It was further purified 
by suspending the crude product in, and washing with ice 
cold water and used as such as was the case with 
oi «=>(2«pyridylthio) acethydrazlde ~l~oxIdeo %t reduced 
ammonical silver nitrate in the cold, and was sparingly 
soluble In water, insoluble In ether, chloroform and 
benzene, soluble in methanol and ethanol from which 
analytically pure samples could be obtained by 
recrystallizatlon0
ALKYLXDENE AND ARALKYLIDENE DERIVATIVES OF^ C<= (2-PYRIDYLTHIO 5)
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ACETHYDRAZIDEo
As with Its 1-oxid©, —(2-pyridylthlo ~
reacted at room temperature with aliphatic and aromatic 
aldehydes and ketones, as well as heterocyclic carbonyl 
compoundso The general method Involved suspension of the 
e* »(2==pyridylthio )acettey&£&&££& in methanol, heating if 
necessary to effect solution and adding on© molecular 
proportion of the appropriate carbonyl compound dissolved 
in methanolo On shaking the reaction mixture for some 
time and leaving it at room temperature, a crystalline 
product eventually separated outo Analytically pure 
samples were obtained by recrystallisation from a suitable 
solvent to constant melting point and removing the last 
traces of adherent solvent in vacuoQ The reaction with
acetaldehyde and butanal was vigorous, and as In the case @f 
th®l«dxide, gave a resinous material which did not 
crystallize from the common solvents0 Preparation of 
sugar derivatives again proved difficult and the product 
separating was too hygroscopic to be isolatedo The 
structure of the alloxan (hexahydro -2,4,5,6- 
tetroxypyx#iMldXzi<3) ' derivative of Xsonlasld N^«(2P4,6<= 
trIox»“5“pyrimidyildene )~N^«,isonicotInylhydrazIn© has 
been formulated as (LXXXXIX) by Pox and Glbasi*®
a? 6
* ®sO
H
(LXXXXIX)
Prom the physical evidence for the structure of alloxan 
the derivative wlth©< ~(2°pyrldylthlo) a&sthyd^sslde-*
Is probably better represented by structure (LXXX1-V) 
rather than structure ■(LX.XXV)0
S
CLXXXIV)
(LXXXV)
The condensation between alloxan and «<~(2~pyridylthlo) 
acethydraside thus parallels that with Isoniazid. and also 
pyridine “4=>sulphonhydrazide o
SYNTHESIS OF ACYL AND SULPHONYL DERIVATIVES QPo( -
(2«FYRIDYLTHX0) ACBTHYDRAZIDE,
®C -(2~PyrIdylthio) -  reacted smoothly 
with acid ohloridesp aol’d anhydrides imd sulphonyl 
chlorides9 giving well-defined crystalline derivatives 
In good yield* according to the followings
CHa~CO~NH-NH-COR
(RCO)
RG0G1 
dry pyri din®
S ’ CH«-C0-NH-NH~0ORR00C1
- s. CHg-C O-NH^NHTos
CHo-CO~NH-NH«COR
Two derivatives were obtained with acetic anhydride* 
depending upon the relative amount of anhydride addedo 
With on© molecular proportion and using methanol or 
dioxan as solvent the monoacetyl derivative (DXXX ? %)
was obtained whilst treatment of the hydrazlde with 
excess acid anhydride gave the diacetat© (LXXXW2|o
•KJHg-CO-NH-M-CO-CHg 
(mcxvi) 
S~CHg~CQ~NH-N . (COCH3 )g
(LXXXVXX)
«< «(2~Pyfidylthlo) acethydrazid© reacted with 
p^sulphonyX chloride in the presence of pyridine to give 
a weXX-defined crystalline producte As before the 
mixture turned orange 9 and wag' heated for X hour on a 
water^bath to complete the reactioiio The product was 
isolated as before by the addition of water and purified 
by recrystaXXizatlon from ethanolo
ATTEMPTED SYNTHESIS OF ALKYL AND ARALKYL DERIVATIVES OF 
^«(2~FYRXDYLTHX0) ACETHYDRAZ IDE 0
Xn view of the antitubercular and MAOX activity of 
substituted hydras ides it if as considered of Interest to 
attempt the synthesis of some alkyl and aralkyl 
derivatives of ©< “(S^pyridylthioJkoethyfirciEldOe
Catalytic reduction of aXkylidene and aralkyXiden© 
derivatives of isonlazld takes place smoothly to give the 
alkyl and aralkyl derivatives in good yield0 Reduction 
of the Sehiffs base linkage of the corresponding
derivatives of «< a(2-pyrIdylthio) however
resulted in hydrogenolysis and regeneration of 
2°mercaptopyridine„ Several other methods were
attempted without success (vide infra) 9
Catalyst
ORR
I£.._h 4
HOI /
RKCH-HH=0Hg/ 
S-CBgOOOEt — —^ -p
-CHs=CO=l!H=NHg
L J L
*CHg=*CO«HE®NH«GHRH
S-CHgc=CO<*KH-B’H-CHRR
CHgCl
base 7
^^ssis»CHg“G 0«>!3H«l3B"CH^ d gBg
SEMIC ARB AZ IKES OF ^ -(2-PYRXI)YLTHI0) ACETHYDRAZ IDE AMD 
ITS l~QUDEo
Allylisothioeyanate and phenyl isocyanate condensed 
with U - (2~pyridyIthl© )actet&y&JtMlito : and its 1-oxide 
respectively in acetonitrile to give the appropriate 
semioarbazidoso
E X  P E R  I  U B S f A  L
PREPARATION OP STARTING MATERIALS 0
2-Mercaptopyridlno was prepared from 2-bromopyridIn© and 
thiourea by the method described by Phillip and 
S h a p i r o a n d  Thirtl©o
* ...
2-Merc apto pyridine-1-oxide was prepared from
2-bromopyridlne-l-oxid® and perbenzoic acid by the
102method described by Shaw, Bernstein, Lose© and Lotto
Perbenzoic acid was prepared by the method described 
In Organic synthesisi*®
Anhydrous Hydrazine:- Hydrazine Hydrate (75go, 1°S mole) 
was added to sodium hydroxide (80go, 2 mole) in toluene 
(6o5 mole)0 After twenty four hours the mixture was 
re fluxed at 120-130° for one hour, access of moisture 
being prevented by a calcium chloride drying tube 
attached to the condenser outlet o The mixture was then 
distilled, the distillate (b0p<> 94-96°) collected, and 
the lower layer consisting of anhydrous hydrazine (50go) 
drawn offo
2-Sulphonamldo pyridine-1-oxlde. 2-Mercaptopyridine-l- 
oxide (l°2g0, 0*01 mole) was dissolved In a cold mixture 
of concentrated hydrochloric acid (7<>5 ml) and water 
(2 ml) and cooled in a mixture of crushed ice and salt^ 
When the temperature had dropped to -10°, chlorine gas
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was bubbled through at such a rate that the temperature 
was maintained at about *=> 5® 0 When the temperature 
started to drop* the flow of chlorine through the mixture 
|?as Increased* and* towards the end of the reaction* It 
was passed vigorously© The reaction was complete when the 
temperature did not rise despite the rapid stream of 
chlorine passing through the solution© The solution 
was treated at «= 5° with calcium carbonate added in small 
portions to effect neutrallzationo Cold chloroform 
(60 ml) was added during neutralization and after 
vigorously shaking the clear chloroform solution was 
decanted from the white sludge which was further washed 
with cold chloroform (40 ml)o The combined chloroform 
extracts were dried (NagS-O^ at 0«5°, filtered* and a 
steady stream of dry ammonia gas passed through© The 
crude product was filtered* washed with cold water and 
dried in a vacuum desiccator© Reorystalllzatlon from 
methanol gave 2 ~sulphonamldopyrldine~l*=oxide as shining 
white crystals (0®4go, 33$) m0po 2280 (Llterature''mopo228?)<>
PREPARATION OF k m  SOME
ARAIEYLXDEBE DERIVATIVES 0
Pyridine~l~oxide°2°aulphonhydr azlde © 2«Me rc apt opy r idin® -1= 
oxide (l°27gb* OoOl mole) was convertedih® pyridine ~1~ 
oxide*>2«8ulphonyl chloride as above© The cold* dry 
chloroform solution of pyridine-l~oxId©=2 -sulphonyl chloride 
was added in portions (1 0 - 2 0  ml) to hydrazine hydrate 
(lgo* 0 ® . 0 2 mol©) and vigorously shaken after each addItion<>
63 o
The mixture was left overnight at 0° and the solid 
filtered and washed with a little ether* The dry 
product was suspended in ice-cold water and sucked dry 
before transferring to a vacuum desiccator« The
product ra0 p0 96~98°, crystallized from methanol as the 
monohydrateo It was sparingly soluble in water9 
methanol and ethanol* and Insoluble in non®polar 
solvents• (Found: C* 28®8; H* 3°9o GgH^NnjO^S requires Cp 
28o9j H* 4»SjO»
l~Bengylidene«2« ( pyrldlne^l^oxide^g-sulphonyl) hydrazine 6 
Benzaldehyde (0«>i06g*, OoOOl mole) in methanol (5 ml) was 
added to pyridine«l-oxide«2~sulphonhydrazide (0°189g*e 
QcOOl mole) in methanol (5 ml) and the mixture 
vigorously shaken till only a faint smell of benzaldehyde 
remained* The white solid which separated was filtered* 
washed with a little methanol and etherp and dried In 
a vacuum desiccator* Recrystallization from methanol 
gave the product (Q<>16 g») as white needles m 0po 145-147° 
(decOmpo) (Pound: Cp52o6j H 94®1j N* 15<>4o C1 2 H 1 3 N3 O3 S 
requires Cp52®0; H*4o0, N, 15o2#)0
l°Veratrvlldena°2~ (pyrldlne~l~oxlde~2~sulphonyl) hydrazine 
Pyrldine~l~oxide«2«sulpbonhydrazide (0®189g * * 0*001 Mole) 
was treated with veratraldehyde (0ol66go, OoOOl mole) 
as described aboveQ Recrystallization from ethanol gave 
the veratrvlldene derivative (0®15 g„) as needles* m0po 
146^148° (deoomp*) (Pound: C,49®2$ H*4olj N* 12o7o
64 o
C12H11°3N3S re<lu**«s 0* 49o8j Hp 4o4| Np12o45# ) 0
Salley lag Ins: Pyridine-l-oxide-2-sulphonhydrazide 
(0°189go, OoOOl mole) reacted with salloylaldehyde 
(0ol22go, OoOOl mole) as above0 The crystalline solid 
separating was recrystallized from ethanol to give 
salicylazine (nupo 210-212°} (Pound: Cp 69*8} Hp 4°8«,
CalCo for C1 4 Hx2 N2 0 2  C, 70o0? H, 5o0#)o 1
I
Attempted synthesis of N-(2-pyrldylthlo) carbonylhvdrazlne 
Method 1
The chloroformic ester (OoOll mole) was added 
dropwlae to an Ice-cold solution of 2 «mercaptopyridine 
(0 ° 0 1  mole) In water (25 ml) containing sodium 
bicarbonate (Ooll mole) and vigorously shaken till only a 
faint smell of the chloro formic ester remained*, The 
mixture was extracted with ether and the ether dried 
(Nag SOg) then removed under reduced pressure to give a 
viscous oil which did not crystallize« The oil (0°lg)
showed maximum absorption at 253 mp0
Method 11
2«Meroaptopyrldlne (0°01 mole) was dissolved in 
N sodium hydroxide (10 ml) and the solution evaporated 
to dryness under reduced pressure*. The residue was 
dissolved in dry alcohol ( 2 0  ml) and ethyl chloroformatc 
(l„lgo, OoOll mole) addedo The mixture was filtered and 
the filtrate evaporated to dryness9 leaving a viscous oil 
(0o05go, 50%) which failed to crystallize*, Distillation
65 o
at 3«0 ~2®0 nnnHg gave a white vlscoua oil which showed 
maximum absorption at 253 mu and an ester peak at 1736
Method III
2<=>Mercapto pyridine (lollgo, 0 © 0 1  mole) was added to 
a solution of ethyl ohloroformate (loiig*, OoOl mole) 
in dry ethanol (3Qml)« The mixture was vigorously shaken 
with occasional warming on a water«bath till a faint smell 
only of ethyl chloro formate remained, and then it was 
evaporated to dryness under reduced pressure <> The 
residue was redlssolved in dry ethanol (2 0 ml) and the 
solution refluxed with anhydrous hydrazine (0 *5 ga) for 
three hours o Removal of the solvent under reduced 
pressure gave a viscous oil which crystallized from 
ether as a yellow solid (lga) mopall8 ° 0 a mixed 
melting point with 2 ^aercaptopyridii^ showed no 
depresslono
PREPARATION 0Pe< ^ (2°mig3TLTHIO) ACETIC ACID ~1«0XIEB 
ITS ACID AMXI3B AND HYDRAZXDEo
e< <=»(2~Pyrldylthlo) acethydrazlde°l~oxlde» 2«Mercapto 
pyridine~X»oxide {3o8ga„ 0°03 mole) was added to a solution 
of ethyl bromoacetate (4o01ga, 0o03 mole) in dry ethanol 
(50ml) o The mixture was refluxed for l£ hour, and then 
evaporated to dryness under reduced pressure0 The 
cream-coloured solid (3°9g«) was refluxed with anhydrous 
hydrazine (0°9ga) in dry ethanol (40ml) for five hr*, and
6©q
then evaporated to dryness under reduced pressure to give
A
a crystalline residue which was suspended In Ice-cold water 
(15ml), quickly filtered, washed with more ice-water (10ml), 
and sucked dry before transferring to a vacuum des locatoro 
Zt was washed with a large excess of ether and again dried 
In a vacuum desiccatoro The hydraslde (2«5g», 75$), 
nupo 200«201° (decompo) crystallised In colourless needles 
from ethanolo ©< »(2~i?yridylthlo)aceth^rs&£de«vl^xid,&:"
Is Insoluble In benzene, ether and.chloroform, sparingly 
soluble In ethanol and soluble In methanol and hot water © 
(Founds C,42°2; H,2Cf°5o (JyHgN^OgS requires 0, 42*2$
Hp 4o5S Np 20oQ%)o
2~Pyrldy lthloaqs ta&ida ? o 2-Mercaptopyridlne-l-oxlde
(l»27go, 0®01- mole) was added to a solution of ethyl 
bromoaoetate (!<>68go, OoOl mole) in dry ethanol (10ml)o 
The mixture was refluxed for l&hr<>, and then evaporated 
to dryness under reduced pressure o The cream coloured salt 
of _ ' ethyl (2«pyrldylthlo)acetaic-‘ (l°6go) was dissolved 
In ethanol (10ml), treated with excess of concentrated 
ammonia at room temperature, vigorously shaken and 
evaporated to dryness under reduced pressures The amide 
(lg6), m0pd 215° (decompo), crystallized In white needles 
from methanolo (Founds 0,45*6$ H, 4o3$ IT, 15©4o C^SgNgO^S 
requires C, 45«>65$ E, 4°5; N, 15o4#)0
2~ryrldylthloacetie acld^ls*oxlde o 2»Mercaptopyridine«l«> 
oxide (l<>27go9 0°01 mole) was converted into ethyl 
(2~pyrldylthio) acetate~l~oxide as described above Q The 
cream coloured solid obtained was refluxed for l£hr with 
water (10ml)o The product (lg«)| mopo288° (deoomp©) was 
recrystalllzed from aqueous methanolo (Found; C, 45*>6;
H, 4°0j N, 7°7o requires C, 45«>4j H, 3<>8; N, 7<>6#)0
The infra-red spectrum showed absorption maxima at 1700om“^ 
and 3400cmo1
PREPARATION OF ALKYLIDENE AND ARALKYLXDENE DERIVATIVES OF 
<  ~ (2<=>,PYRIDyLTHI0 ) ACETHYDRAZIDE~1~QXIDB 0
N^Bensy lldene^Q^ (2^yrldylthlo )acethydrajside»l'=oxid^ i> ^ 
^*»(2®Pyridylthlo) acethydrazide~l«oxlde (0®398go, 0°05 mole) 
in methanol (5ml) was added to be nz aldehyde (0°212g©) 
in methanol (5ml) and the mixture vigorously shaken till 
only a faint smell of benzaldehyde remained0 The
mixture was then left overnight in the refrlgeratoro The 
white crystalline solid which separated was filtered* 
washed with a little methanol and ether, and dried in a 
vacuum desiccator Recrystallization from methanol gave 
the benzylldene derivative as white needles (0°4g.) uup© 
202«203° (decompo) (Found: C, 58o5j H, 4°55; N, 14o95Q 
^14^13^3°2® requires C, 68<>5; H, 4o5; N, 14o7#)0
68 o
i
N-Salleylldene- of-(2-pyridylthlo 1 acethydrazide-l-oxlde 0 
oC» (2= Pyridylthio k c o ( 0 ° 3 9 8 g „ ,  0o06mole) 
was treated with salioylaldehyde (0»244g., 0«05 mole) in 
the manner described for N^bensylidene (2=.pyridy lthio) 
acethydrazlde=l=oxide. The shite crystalline solid which
separated on standing was filtered, washed with a little 
methanol and ether and dried In a vacuum desiccator.
Re crystallization from methanol gave the salloylldene 
derivative as needles (0o41g)„ mPp0 230-232° (decompo)
(Pounds C, 55*55* H, 4*0; N, 13o9« C14H13N30^5 requires
Op 55*45; Hp 4*3; N„ 13o9#)0
f
N-Isopropylldene«*<- (2-pyrldy Ithlo) acethydrazide-l-ox3.de o 
oC«(2«Pyridylthio) acethydrazide»l-oxlde (0oS98gop 0*05 mole) 
was treated with excess acetone 0 The mixture was
vigorously shaken for some and. then evaporated to dryness
under reduced pressure« The residue was crystallized from 
ethanol to give the laopropylldene derivative (0°4go)
Hupo 210-211°(decompo) (Pound: C,50o3; H, 5*3; N, 17*7o 
C^oHx^NgOgS requires C„ 50*3; H, 5*4; N, 17°6#)<>
j/-Plperonylldene-«i- (2-pyrldylthlo) aoethydrazlde-l-oxlde a 
vC ~(2«PyridyIthlo) acethydrazide-1-oxide (0«398g», 0*05 mole)
was treated with plperonal (0*3g©, 0*05 mole) as 
/
described for N-salicylidene^f-(2-pyridylthio}
acethydrazide-1-oxide© The product (0<>41g©) m©p ©807-2080
was obtained by recrystallizing the precipitate from 
methanolo (Pounds C, 54°2; H* 3o9| Np 12oloc15H13N304S 
requires C, 54°4; Hp 3°9j N* 12°7#)0
N ^lLoC <*Pheny le thy lidene )°°<°(2~ pyr idy lthio) acethydrazlde-l- 
oxideo Acetophenone (0°152g<>p 0°05 mole)in methanol 
(5 ml) was added to©< -(2-pyridylthio) acethydrazide di­
oxide (0o398gop 0°05 mole) in methanol (5 ml) and 
re fluxed for one hour© The mixture was concentrated and 
left overnight at room temperature to crystallize0 The 
product (0°42go} m*p0 201-203°(decomp0) was obtained by 
recrystallizing the precipitate from methanole (Pounds 
C p 60°5| Hp 5°0j Np X3°5o C^gH^gNgOgS requires C p *59°9f 
Hp 5«0| Np 13°8^)0
N-Veratrylidene-eC- (2-pyridylthio) acethydrazide-1-oxtd® s
■ jmiwmiwiwiirTflM Tr^M irirf ' 11 ■ ir«— i«m iBiJiiir iiTrflrrn-“« i iHfvn irti 1 i i  ii"’"  rr^- 1 ■ ■» n -rr~— ~   —
oC-(2«.Pyridylthio (0e398go& 0°Q5mole)
was treated with veratraldehyde (0ol66gOp OoOS mole) 
as described under the benzylidene derivative © The 
product (0°42go) m 0p0 213-214°(decomp©) was obtained by 
recrystallizing the precipitate from methanol© (Pounds 
C, 54°8$ Hp 5°1; o Ci6H17Ng04S requires C, 55°0jp H, 5°0$)o
l/»Dlmethylamlnobenay 11 dene (g-pyrldyIthlo) acethydrazide
-l-oxldeo «^-(2-Pyridylthio - (0o398gop
0°05 mole) was treated with p-dime thy lamlnobenz aldehyde 
(0o298gop 0o05 mole) as above© A crystalline solid had
separated after four days© Recrystallizationfrosa:ethanol
70o
gave the product (0«38go) as needles m 0p0 218~220°(decompo h  
(Pounds C j,58o6; Hp 5°5P Np 16©2. CxgHxgN^GjgS requires 
C, 58o2j H, 5o45; Np X6o6#)0
I
fi4ff6^trloy£^_5-pyrlmidylldene^(2^pyrldylthlo) 
acethydraziae~l~oxlde0 (2~PypldyIthlo) acethydrazide
oxide (0©398gop 0o05 mole) was treated with hexahydro~2p4,59 
6-tetrc^ /p^ ;?lHild£ni» (0«33gOp 0«05 mole) as before<> The 
solid which had separated after three days was filtered* 
washed with a little methanol and recrystallized from 
methanol to give the product (0°4go) m©po 183°( decomp©) 
(Found: CP 37o8j? H, 5o8f Np 19ol^ 0 CxiHgNgOgS requires 
Cp 38o0j Hp 3o5| 20o0^)o
lM31nnamylldene°g<~(2°pyrldylthlo) acethydrazlde~l«oxlde 0 
°C~{2<=PyrldyIthlo) acethydrazIde~l°oxide (0o398goy 0«05 mole) 
In methanol (5 ml) was treated with clnnamaldehyde 
(0°132goP 0^05 mole)in methanol (10ml)© The product 
(0o42g<>) m©p0 220«2S83° (decomp ©) was obtained by 
recrystallizing the precipitate from methanol© (Pound:
C, 61°55$, H, 4«9j Ne 13o3c CigHxgNgOgS requires Gp 61*55$
H p 4*8; N, 13o5^)o
rf~VanlIlylldene«c<*> (2-pyrldylthlo) aeethydraglde~i~oxld_eo 
oC«(2«PyridyIthlo) acethydrazlde~l«oxide (0o398gOf) 0o05mole) 
In methanol (5ml) was treated with vanillin (0°304g©p 
0°05 mole) in methanol (5ml)o The solid which separated 
was filtered* washed with a little methanol and ether and 
dried in a vacuum desiccator© Recrystallization from
71o
methanol gave the product ( 0 o 3 g o ) as needles m 0pc 1 9 8 - 2 0 0 °  
(decompo) (Pounds C, 54o2; H* 4°55; N* 12°80 C15H15Ng04S 
requires Gs 53o9; H* 4o6; N* 12o3$)„
flt (fl-Phenyle thylldene) (2-pyridyIthlo) aoethydrazlde-l~
oxideo *2 ~(2=Pyridylthio) act©hydrazide-1-oxide (O°398go0 
0°05 mole) in methanol (5ml) was treated with freshly 
distilled phenylacetaldehyde (0°212go) in methanol (XGml)o 
After four days the solid which had separated was filtered* 
washed with methanol and ether0 Recrystallization from 
methanol gave the product (0<>31go) as needles m 0p0 190=191° 
(Pounds 09 60°0j, H* 5«>2| N* 10©0o C^g h15h3oss requires 
C* 59q8| Hp 5°0; H* 10<>3#)o
f)
N-Acetylisopropylldene°cC=(2-pyrldylthio) acethydrazide-l- 
oxideo ^  ={2-Pyridylthio) acethydrazlde-l-oxide (0o398go?> 
0°05 mole) was treated with aeetylaceton© (032go* 0°05 mole) 
as described above 0 The white crystalline solid which 
separated was filtered* washed with methanol and ether 
and dried in a vacuum desiccatoro Recrystallization 
from ethanol gave the product (0< 32go) as fl&e needles o 
m 0po 175° (decompo) (Pound: C*51o25j Hp 5°7$ H* 15«4o 
c 12H15N3°3S c> 51c25; H* 5“3; N, 14o9#)o
N-Purf urylldene-qC- (2=pyridyIthlo) acethydrazlde-l-oxjde o 
(Sf«(2«PyrldyIthlo) acethydrazlde-l-oxide (0o398go* 0o05mole)
was treated with furfuraldehyde (0ol92go* 0o05 mel©)
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in methanol (10ml)p and the solid separating filtered^ 
washed with methanol and ether and dried in a vacuum 
desiccator* Recrystallization from ethanol gave the 
product (Oo^) as fine needles* m*p0 180~182° (Founds 
C, 51°9; Hp 4o2; N, 15<>8. C^Hll^OgS requires 0, 52o0j 
H, 4°0j N, 15°4#)0
CONDENSATION OF* - (2-PYRIDYLTHIQ) ACETBYDRAZIDB-1-QXIDB WITH 
ACID ANHYDRIDES. ACID CHLORIDES AND SULPHONYL CHLORIDES,
N~Dlacetyl«*C~(2-pyrldylthio) acethydrazlde~l«oxlde o 
o<«(2-Pyrldylthio) acethydrazlde«l»oxida (0°398gop 0 °05 mole)
* was added in small portions to sscefii® ssahy&ridi? .
(5ml) and warmed till solution was complete o On cooling 
the crystalline solid separating was filtered^ washed with 
a large excess of ether to remove acetic anhydride and dried 
in a vacuum desiccator* It was twice recrystallized from 
methanol to give the diacetyl derivative (0°4go) as needles 
nupo 135° (decompo) (Founds C 9 44o5j# H, 4«8| Np 14o9o 
CnHigNgO^S requires C, 45°2j Hp 4°6s Np 14°3#)<>
lj~B~HydroxvcarbonvIprftsS,&uy 1 W -  (2-pyrldy Ithlo) acethydrazlde 
~l~oxlde o e< »(2«=»PyrldyIthlo) acethydrazide-l^oxlde (0*398gop 
0®05 mole) was added to succinic anhydride (0o2gop 0<>05 mole) 
in methanol (lOml)o The solid separating was twice 
crystallized from methanol to give the product (0o4g„) as 
needles* m0po 200-201°(decompo) (Founds Cp44o4j Hp 4*55$
Np14o85o Cn Hi3N30gS requires C, 44ol- H„ 4o35j N, 14<>06#)o
~Toluene^p^su lphony l°o<»(2~pyrldylthio) acethydrazlde~l~ 
oxideo &  **(2» Pyrldylthio) acethydrazide-l-oxlde (0°398gop 
0<>05 mole) in dry pyridine (IQml) was treated with 
toluene-p~sulphonyl chloride (0o05 mole) and the mixture 
heated on a water-bath for 15 min0 The mixture was 
cooled and an excess of distilled water added* After 
three hours a white crystalline solid had separated*
This was filtered* washed with a little water and dried 
in a vacuum desiccator* Recrystallization from ethanol 
gave the toluene-p-su 1 phony 1 derivative (0<>29g<>) as 
needle mep<> 242° (decompo), (Found: C 9 47°4; H„ 4°5;
^14^15N3°4% 2,®Qu*res C, 47o6; Hp 4°2/6)0
t ■4
N-B~Hydroxycarbony laery loy l~o<- (2~pyrldylthio) acethydrazlde 
-1-oxide * oC «(2~Pyridylthlo) acethydrazlde~l«oxlde (0*398g*p 
0°05 mole) was treated with malelc anhydride (0«05 mole) 
as described for N~p-hydroxycarbonylpropionyl-*<- (2~ 
pyrldylthio )acethydraslde^ l-oxldco ’ The crystalline
solid separating was filtered,, washed with a little 
methanol and ether and dried in a vacuum desiccator* 
Recrystallization from methanol gave the product (0*3 g*) 
m 0po 110-113°0 (Found: C„ 44o8j H* 4»2| N* 14o9*
C^iHj^NgOgS requires C 9 44<s4j H* 4*0j Np 14*15$0o
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i rJ g  d ^ t ; h l o J ^ ^ c e t j r l  ^ 4 -p h Q n y l3 eM o a r b a z l d Q - l - o x i d ®  0 
<rt-(2-PyrldyIthio) acethydrazlde-l<=oxide (0°398go* 0°05 mole) 
was treated with phenylisocyanate (0o2g0* 0o05 mole) in dry 
acetonitrile (10ml)o The mixture was vigorously shaken 
for 1 hr®, and evaporated to dryness under reduced pressure* 
The white crystalline solid remaining was recrystallized 
from ethanol to give the semlcarbazlde (0o2g«) as needles 
mop* 194<=»195°o (Pound: C, 52o7| H* 4*2; N* 18o0*
C14H14N4°3S re<lulres c*> 52o8I H* 4o4S Np 17o7^)0
ct, ^ (2°PyridyIthlo) acethydroxamle acld~l°oxlde0 
Method X
Ethyl (2-pyrldylthio) acetate =>X<=oxide (l°6g0) was 
added to an 85# solution of potassium hydroxide (3ml) 
in methanol (15 ml) containing hydroxylamin© 
hydrochloride (0o6ge)o The potassium chloride was filtered 
off* washed with a little methanol and the filtrate and 
the washings left at room temperature to crystallize 0 The 
solid - separating was dissolved in a mixture of water 
(10ml)p neutralized with acetic acid but the product failed 
to separateo
Method XX
Ethyl (2°pyrldyIthlo) aoetate»l~oxIde (l°6ga) was 
added to a solution of hydroxyl amin® hydrochloride (l°lgo)
In methanol (15ml) containing sodium methoxlde (lolg0)0 
The precipitate was quickly filtered and washed with a
little methanol® The combined filtrate and washings 
were concentrated to small volume under reduced pressure 
and left at room temperature to crystallize® The 
hydroxamic acid _(0°5go) separated In fine needles® 
m 0po 195-197° (decompo) (Pound: C*41o9| H, 4o2,
CipHgNgOgS requires C, 42®0j H, 4°0#)o
PREPARATION QF<* - (2-PYRIDYLTHIQ) ACETHXDRAZIDE AND ITS 
DERIVATIVESo
•MNMBaflBMMWMHtaMnBM
-(2-Pyrldylthlo) aeethydrazlde ® 2-Mercaptopyridlne 
(lollgo, 0501 mole) was added to a solution of ethyl 
bromoacetate (lo67g®, Oo01 mole) in dry ethanol (30ml)* 
refluxed.te two hr®, and evaporated to dryness under 
reduced pressure* The off-white solid (1^3g®) was 
refluxed with anhydrous hydrazine (0o99go) in dry 
ethanol (40ml) for 5«6hr0, and again reduced to dryness 
under reduced pressure* The residue was suspended in 
ice-cold water (10ml) and then sucked dry before transferring 
to a vacuum des locator * The dry solid was liberally washed 
with ether and crystallized from ethanol to give the 
product (l*2g0) as needles® m 0p0 90-92° (Found: 0,460011 
H„ 4*9$ N, 22o9o C r ^ % 0  S requires 0, 45*9j H, 4*9$
N, 22°2#)b
ALKYLIDENE AND ARALKYLIDENE DERIVATIVES 0FU-(2-FYRXDYLTHX0) 
ACETHYDRAZIEEo
?/-Benzylldene-c&»(2-pyrldylthio) acethydrazide* oC-(2~ 
Pyrldylthio) acethydrazlde (0°183g,>, OoOOl mol©) In
methanol (5ml )twas added to benzaldehyde (Q°106gop OoOOlmole) 
In methanol (5ml) and vigorously shaken till only a 
faint smell of benzaldehyde remained 0 It was left 
overnight to crystallize and the solid washed with a little 
methanol and ether and dried In a vacuum desiccators 
Recrystallization from methanol gave the benaylldene 
derivative (0o2go) as needles® m 0p0 191-192°® (Pounds 
C* 62<>0f H, 4o7* N* 14«>5o ^X4%3^3° ^ requires 0, 62°0£
H, 4o75| N* 14o9#)*
lt-Salicylldene-*- (2~pyrldyIthlo) ace thydrazlde *
-(2-Pyridylthio} acethydrazlde (0ol83g<>„ Oo001 mole) 
in methanol (5ml) was added to salicylaldehyde (0<>122go, 
OoOOl mole) as described above* Recrystallization 
from ethanol gave the salicyXidene derivative as needles 
(0°2g®) m ep0 200-201° (decompo) (Founds C p 58°25$ H, 4<>8|
N, 14o6o Gx4Hi3i%°2S requires Q& 58° 5? YxB 4«»5| N* H 4 ^ ) (
fl-Iaopropylldane^*.- (2=pyrldyl1:hloJ; aoathrdgaglMo 
<*-(2-Pyridylthio) acethydrazlde (O^lSSgo, OsOOl mole) 
was allowed to react with acetone (10ml) and the solid 
recrystallized from ethanol to give the product (0*2go) 
as needles* m 0p0 128-130°* (Pounds 0, 53«5| H* 5p8°
N, 19*0* CxO^lB^S0 S requires C* 53°8| H* 5°8| N, 18p8#)0
j- Phenvlethy 1 idene )**<- (2-pyrldylthio) acethydrazlde *
«4<=>(2« Pyrldylthio} acethydrazlde (0ol83go„ 0°QQ1 mole) 
in methanol (5ml) was added to acetophenone (0®Xg°,
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0*001 mol©) In methanol (IGml) and th© solid separating 
recrystallized from ethanol to give the product (0°21ge)
AicaBanBawisaaRp “
as fin© needles* m0po 142-144°0 (Founds C, 63*1$ H9 5*551 
N, 15*0o C15H15N30 S requires G p 63ol5f Hp 5*4; Np 14*8$) 0
O *-(8«
Pyrldylthio) acethydrazlde (0°183gop OoOOl mole) was 
mixed with piperonal (Ods gop OoOOl mole) In th© 
manner described for the sallcylldene derivative above 
and th© light cream-coloured solid obtained re crystallized 
from ethanol to give th© product (0°19go)- m0po 167-170° 
(Founds Gp57o4| HP 4*3; • requires Cp S7*lf
H, 4 ° 1$) 0
I
N-Veratry Ildene-^- (2-pyrldylthlo) acethydrazlde Q eC *(2® 
Pyrldylthio') acethydrazlde (0ol83gOp OoOOl mole) was 
added to veratraldehyd© (0ol66g0j) OoOOl mole) as 
described above0 Eecrystallizatlon from ethanol gave 
the product (0°199go) m0po 138-141© (Founds Cp. 57°6g 
H„ 5«4o C^gH^NgOgS requires C<» 57*9$ H s 5*2$)0
l/~Hexahydro-2 a4 a6-trl03gr~5~pyrlmldylldene-*< - (2- 
pyrldylthio) acethydrazldeP d -(2-Pyrldylthio) 
acethydrazlde (0°183gop 0°001 mole) was treated with 
hexahydro^2,4,5p6»tetre^ypyrlmIdi5m (0*001 mole) in 
methanol (5ml) o The mixture was vigorously shaken and 
left to crystallize* Re crystallization from methanol
gave the product (0°2go) mbpo 290° (decompo) as th© 
monohydrate* (Founds 0„ 40oB| H p 3o9| 21*9*
C11H X1W5°5S cs> 40o9| H* 3o4$ N* 2Iq6#)o
N ^Djine t&ylamlnob® nz y 1 Id© n© - oi ~ (2- Dvridv X thi o) acethydrazlde ® 
o<«(2«PyridyIthlo) acethydrazlde (OoX83g0j> OoOOl mole)
In methanol (5ml) was treated with p~dlm@thylemin©b©nzaldekyd@ 
(0o00Xmo1©) as described above® RecrystaXXIzatlon from 
methanol gave the product (0®29go) as needles® m0po 186^188? 
(Founds C, 60®9$ H* 5°7o S requires C* 6X°0|
H* 5°7$)o
]
N-C Innaraylldene-eC- (2° pyrldylthio) aoethydraz Ida 0 o( °(2=
in w i n  ■mu ■[■Mi t i n w r  in  i ^ tw r n    —r m m  rm n ir rn irtim n B ii ffl hiimh mu iwi n i iiiiiit ■ n  - r  j , ,  ,
Pyrldylthio) acethydrazlde (0ol83gCf, 0^001 mole) was 
treated with climamaldehyd© (0oX39go, 0©001 mole) as 
before to give th© product (0°X6g®) as needles® m0p0 
135^136°o (from methanol)® (Founds 0, 64°2f H5 4©9|
N„ 15°7o C^gH^gNgO S requires Cp 64»6f Hp 5°0| 15°X$)o
N^VanlllyXldene°e<- (2-pyrldylthio) acethydrazlde 0 ©< -(2-
fmtyTTTUU 11 111 1     (l-1 —~* ■ " • !ii.'"i . ■ r «■"!.. jmpw3!i i T»»u jL»n. ■OjLi7.-'hlx
Pyrldylthio) acethydrazlde (0ol81gog 0^001 mole) was 
treated with Vanillin (G°152go * OoOOl mol©) as before to 
Klve the product as th© h^mlhydrate *> m0p0 165-167°
O  i j S w i i m  iif - n M i Hin
(Found: C, 55°75| H* 5-4® C^sH^gNgOgSp iHgO requires 
C, 55*4; Hp 4°95#b
h  (B-Phenylethyllden® )-<*- (2-pyrldylthio) acethydrazlde 0 
<*«(2«PyridyIthlo) acethydrazlde (0*>183go<) OoOOl mole) 
was treated with freshly distilled pfaenylacetaldehyd©
(0*001 mole) as before to give the product (0*198go) 
m®po 152-153°(from methanol)0 (Found: C P 62o9| 5<>4$
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N, 15*4® C15H15K30S requires C, 63°0; n 9 5°5f NP 14*7$)o
N«Cyplohexylidene-o<c» (2«pyrldylthlo) acethydrazlde o & «*{2« 
Pyrldylthio) acethydrazlde (0*183g®p 0<»001 mole) was 
treated with cyclohexanone (0o96g®, 0*001 mole) as 
before to give the product (0®19g®) as needles® m 0po 
112~114° (from methanol)® (Pound: C, 59*35; H, 6o6« 
C13H17N3° s requires C, 59*35; H* 6*45#) o 
?
N°p~Me thoxybenzylldene^*^ (2«pyrldyIthlo) acethydrazlde o 
o*~(2«Pyrldylthio) acethydrazlde (0<>i83go9 0*001 mole) was 
treated with p-methoxybenzaIdehyd© (0°136go* 0*001 mole) 
in methanol (10ml) and the solid separating recryatalllzed 
from methanol to give the product (0olgo) as needles 
m®po 136<=>138° (Pound: C, 59o5; Hs Sol. C15H15N30gS 
requires Cp 59*8; Hp 5*0$)0
^ p  ^  y  ^  ^  y  y
©4®(2«=»PyrldyIthlo) acethydrazlde (Q°183gop 0*001 mole) was 
treated with p~hydroxybenzaldehyde (0*122gOp 0*001 mole) 
as before to give the product (0ol5go) m®po 194° (decamp®) 
(from methanol)® (Found: C9 56*7; H„ 4*7® G14Hi3N302S 
requires Cp 56*3; Hp 4*7$) o
CONDENSATION QFo( ~(2^FYRIDYLTHI0) ACETHYDRAZIDE WITH ACID 
ANHYDRIDES. AOID CHLORIDES AND SULPHONYL CHLORIDE® 
lf~Dlaoetyl~ofr»(2-pyrldylthio) acethydrazldeo <* ~(2^ 
Pyrldylthio) acethydrazlde (0°183gOp 0*001 mole) was 
added In small portions to freshly distilled acetic 
anhydride (5 ml)o The mixture which solidified
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immediately was sucked dry at the pumpp washed with a 
large quantity of ether and dried In a vacuum desiccatoro 
Recrystallization from ethyl acetate gave the dlacetyl 
derivative (0ol9go) as needles m.po 141-143°. (Pounds 
C, 47«9; 4°9* CijH^gNgOgS requires C, 47e75; H, 5°l$)o
N°p-Hydroxycarbonylpro plonyI-*-(8-pyrlflyIthlo) acethydgazIdea 
®< =(2~PyridyIthlo) acethydrazlde (0ol83g., 0°001 mole)
In methanol (5ml) was treated with succinic anhydride 
(0°116gop 0*001 mole) in methanol (5mX)0 The crystalline 
solid which separated gave the product (0°2go) as needles 
m 0p© 150<=>151° (from isopropcmnol) (Found; G p46°2$ H9 4°7o 
^11®13%°4^ requires C9 46 <*55$ Hp 4®6#)o
B-Acetyl-oC- (2-pyrldylthio) acethydrazlde Q e€ »(2-Pyrldylthio) 
acethydrazlde (0°X83goe 0°0Q1 mole) in pyridine (5ml) was 
treated with acetic anhydride (OolBgop OoQOX mole) in 
dry pyridine (5ml)o The solid obtained was recrystallized 
from ethyl acetate to give th© acetyl derivative (0°Xgo) 
as needles* m*p0 138-140°o (Pound; Cp 48°0j H P 5®1| 17°3a-
CqH^ NaOgS requires C, 48«0j Hp 5<>0| Np 18oi$)0
lf«Toluene -p-sulphony (2-pyr idylthlo) acethydrazlde 0 To
eC - (2«= pyrldylthio) acethydrazlde (0*366go* OoOSmole) 
in dry pyridine (10ml) was added to luene-p-sulphonyl 
chloride (0®38go„ 0*05 mole)© The mixture was heated on a 
water-bath for 10 min© and allowed to cool to room 
temperature © Water (50ml) was added and the white solid 
which had separated after Ihr©, was filtered,, washed and
81o
dried in a vacuum deslocatoro Recrystallization 
from ethanol gave the product (0«lgo) m<,po 165-16?°*
(Pound; G* 49*3; H„ 4<>60 C-^H-gNgOgSg requires C, 49o8|
H, 4o45^)o
lco < ”(2°Pyridylthio)acc/ayl^4°aliylthiosemicarbazideo < -(2 = 
Pyrldylthio) acethydrazlde (Q°366go0 0®05 mole) in 
acetonltrile (5ml) was added to allylisothiocyanate
(0°198gop 0*05 mole) and th© mixture heated on a water- 
bath for 10 mine* then allowed to cool to room 
temperatureo Recrystallization from ethanol gave the 
product (0*>32go) (m0p,,1X6=117°) (Found: C« 18*33 E.: & 0 o 9 
®iiH442*°8s '^’Sy'sf.rss S,"4«?8j H, 5°0%)o
ATTEMPTED SYNTHESIS OP ALKgL AND ARALKYL DERIVATIVES OP 
e<~(S°PgRXDrLTHIO) AOBTKCTRAZSIB.
Ao Method lo
N - J s o pro py 11 d© n © =(2 «=» py r 1 &y 1 thio) acethydrazlde 
(lg0j? 0°QQ45 mole) was dissolved in methanol (20 ml) and 
hydrogenated at room temperature and atmospheric pressure 9 
using Adam*s platinum oxide catalyst (0°lgo)o There 
was no uptake of hydrogen and on filtration and 
evaporating the solution to dryness starting material was 
recoveredo
Method IXo
$«Benzylidene-*« (2-pyrldylthio) acethydrazlde 
(Iga, Oo004 mole) was dissolved in N methanolic
82 o
hydrochloric acid (20 ml) and hydrogenated under 
pressure* using Adam’s platinum oxide catalyst (0«lgo)o 
On filtfcriagL; and evaporating the solution to dryness a 
yellow solid was obtained (m0po 118°)0 A mixed 
.melting point with 2«mercaptopyridine showed no 
depression*
MethodlXlo
Finely devlded iron powder (l°0go) was added 
to a boiling solution of ]f~benzyXXdene~*~(2»pyrldylthio) 
acethydrazlde (Igo* 0o004 mole) in ethanol (15 ml)<> 
Concentrated hydrochloric acid (10ml) was added dropwiae 
over a period of 30 min*, and th© mixture refluxed for 
a further l§hr<>* before taking down to dryness under 
reduced pressure« The solid was redissolved in water 
and neutralized with ammonia0 Removal of the solvent 
gave a whit© solid (m0pc 90° )G A m£xe& malting point 
with authentic o(-(2«pyridylthio)ae^t.l5^dr^ixVgf' showed 
no depression
Method X o
Ethyl«< -(2-pyridylthio) acetate hydrobromide 
(Igo, 0o0035 mole) in ethanol (20 ml) was treated with 
sodium ethoxide (0°34go)o The sodium bromide was 
removed and the solution heated at 120° under reflux 
with unsymmetrical dlisopropylhydrazin© (0o48go) 
for six hr© Removal of the solvent gave a viscous oil 
which did not crystallizeo
B3o
Method IIo
6C■=>(2<= Pyrldylthio) acethydrazlde (Igo* 0<>0052 mole) 
In pyridine (20 ml) re fluxed with benzyl chloride 
(0*005 mole) for six hr0» gave a white solid which was 
not identifiedo
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